NASDAQ · RMTI
Healthcare · Drug Manufacturers - Specialty & Generic
$8.65
Up+$0.08 (+0.93%)
Updated Oct 3, 2026, 8:55 AM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · RMTI
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
RMTI closed at $8.65 after 20 trading sessions, up 8.33% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $8.51 | $8.73 | $8.50 | $8.65 | 12.59K |
| Oct 1, 2026 | $8.42 | $8.74 | $8.42 | $8.57 | 11.13K |
| Sep 30, 2026 | $8.74 | $8.74 | $8.29 | $8.54 | 21.26K |
| Sep 29, 2026 | $8.60 | $8.73 | $8.53 | $8.68 | 12.97K |
| Sep 28, 2026 | $8.54 | $8.74 | $8.26 | $8.63 | 17.66K |
| Sep 25, 2026 | $8.42 | $8.56 | $8.35 | $8.37 | 6.43K |
| Sep 24, 2026 | $8.59 | $8.7009 | $7.91 | $8.57 | 15.85K |
| Sep 23, 2026 | $8.2612 | $8.8295 | $8.2612 | $8.57 | 9.54K |
| Sep 22, 2026 | $8.7396 | $8.88 | $8.46 | $8.855 | 27.31K |
| Sep 21, 2026 | $8.15 | $8.90 | $8.0586 | $8.70 | 59.67K |
| Sep 18, 2026 | $7.95 | $8.229 | $7.5005 | $8.065 | 44.48K |
| Sep 17, 2026 | $7.89 | $7.91 | $7.8006 | $7.91 | 5.61K |
| Sep 16, 2026 | $7.85 | $7.90 | $7.7801 | $7.80 | 2.92K |
| Sep 15, 2026 | $7.699 | $7.96 | $7.699 | $7.85 | 6.47K |
| Sep 14, 2026 | $7.95 | $8.03 | $7.78 | $7.78 | 5.88K |
| Sep 11, 2026 | $7.87 | $8.34 | $7.87 | $7.96 | 42.75K |
| Sep 10, 2026 | $7.85 | $8.10 | $7.5106 | $8.04 | 36.51K |
| Sep 9, 2026 | $7.72 | $8.18 | $7.28 | $7.955 | 21.39K |
| Sep 8, 2026 | $7.93 | $8.11 | $7.50 | $8.06 | 33.18K |
| Sep 4, 2026 | $7.8992 | $8.09 | $7.7805 | $7.985 | 6.58K |
The latest Smart Investors Daily articles mentioning RMTI.
Company
Market Activity
Research & News
RMTI research
Company profile and research snapshot.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 11, 2026 | HC Wainwright & Co. | Buy | — |
| Jul 9, 2026 | HC Wainwright & Co. | Buy | — |
| Mar 30, 2026 | HC Wainwright & Co. | Buy | — |
| Jan 26, 2026 | HC Wainwright & Co. | Buy | — |
| Nov 13, 2025 | HC Wainwright & Co. | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 22, 2026
Minot Light Capital Partners, an investment management company, released its Q2 2026 investment letter. A copy of the letter can be downloaded here. In the quarter, the partnership generated gross and net returns of 26.2% and 20.3%, respectively, bringing year-to-date returns to 22.8% gross and 17.1% net. Since inception 21 months ago, gross and net […]
Benzinga · Sep 11, 2026
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $20 price target.
SeekingAlpha · Aug 17, 2026
2026-08-17. The following slide deck was published by Rockwell Medical, Inc.
SeekingAlpha · Aug 13, 2026
Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call August 13, 2026 8:00 AM EDTCompany ParticipantsHeather Hunter - Senior VP & COOMark Strobeck -...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning RMTI.
